ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

ISPC iSpecimen Inc

0,2697
0,0032 (1,20%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
iSpecimen Inc ISPC NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
0,0032 1,20% 0,2697 06:00:12
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,27 0,26 0,2778 0,263 0,2665
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
25/4/202414:00GLOBEiSpecimen to Report First Quarter 2024 Financial Results on..
14/3/202413:00GLOBEiSpecimen Reports Full Year 2023 Results
13/3/202400:07GLOBEiSpecimen Reschedules Full Year 2023 Earnings Release and..
05/3/202422:30GLOBEiSpecimen to Report Full Year 2023 Financial Results on..
05/3/202415:26EDGAR2Form 8-K - Current report
05/3/202415:24EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
15/2/202423:09EDGAR2Form 8-K - Current report
08/2/202422:10EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
23/1/202413:30GLOBEiSpecimen and TriMetis Life Sciences Announce Strategic..
22/1/202422:15GLOBEMaxim Group LLC to Host the 2024 Healthcare IT Virtual..
18/1/202414:11GLOBEiSpecimen to Participate in Maxim Group Healthcare IT..
21/12/202322:15EDGAR2Form 8-K - Current report
07/12/202313:30GLOBEiSpecimen Strengthens Global Oncology Biospecimen Offering
02/11/202314:01EDGAR2Form 8-K - Current report
02/11/202312:30GLOBEiSpecimen Reports Third Quarter 2023 Financial and Operating..
02/11/202311:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
26/10/202313:30GLOBEiSpecimen Expands Proprietary Provider Network to Help..
23/10/202313:45EDGAR2Form 8-K - Current report
23/10/202313:30GLOBEiSpecimen Preannounces Third Quarter 2023 Revenue Increase..
10/10/202323:29EDGAR2Form 8-K - Current report
28/9/202313:30GLOBEiSpecimen Launches Next-Day Quote Service for Medical..
15/9/202322:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202313:30GLOBEiSpecimen Expands Provider Network to Enhance Support for..
06/9/202322:16EDGAR2Form 8-K - Current report
06/9/202322:05GLOBEiSpecimen Announces Organizational Changes to Enhance..
30/8/202313:30GLOBEiSpecimen Launches New Virtual Cancer Sequencing Procurement..
16/8/202313:30GLOBEiSpecimen Enhances Proprietary Marketplace Platform to..
09/8/202313:30GLOBEiSpecimen Introduces New Marketplace Functionality to..
02/8/202315:15EDGAR2Form 8-K - Current report
02/8/202313:00GLOBEiSpecimen Reports Second Quarter 2023 Financial and..
02/8/202312:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
25/7/202313:30GLOBEiSpecimen to Report Second Quarter 2023 Results on August 2,..
07/7/202323:20EDGAR2Form 8-K - Current report
06/7/202313:30GLOBEThirteen New Biospecimen Suppliers Added to iSpecimen’s..
23/5/202313:30GLOBEiSpecimen to Participate in Maxim’s Healthcare IT Virtual..

Dernières Valeurs Consultées

Delayed Upgrade Clock